牛分枝杆菌MPB70蛋白单克隆抗体的制备及检测

为了制备牛分枝杆菌的单克隆抗体,本试验利用制备的原核表达的牛分枝杆菌重要抗原蛋白MPB70作为免疫原皮下多点注射免疫BALB/c小鼠。利用细胞融合技术,经过5次亚克隆与筛选,取已免疫好的小鼠脾细胞与SP2/0骨髓瘤细胞在PEG3500的作用下进行细胞融合。筛选得到了2株分泌抗牛分枝杆菌MPB70蛋白的杂交瘤细胞,分别命名为Anti-B-MPB70:8和Anti-B-MPB70:12。采用间接ELISA方法对获得的单克隆抗体进行亲和常数检测、效价分析及亚类鉴定,通过SDS-PAGE凝胶试验对单克隆抗体进行纯度分析,并检测其浓度,通过Western blotting方法对单克隆抗体的反应特性进行鉴定。结果显示,纯化后的MPB70蛋白分子质量大小为20 ku,浓度为0.5 mg/mL。两株单克隆抗体的亲和常数分别为9.95×10~9和9.53×10~8;抗体效价分别为1∶102 400和1∶12 800;抗体亚类分别为IgG_(2b)和IgG_1,轻链类型均为κ型;纯度90%;浓度分别为3.0和2.2 mg/mL;且具有良好的反应特性。以上研究结果表明,本试验成功制备了抗MPB70蛋白单克隆抗体,可为牛结核病病原和抗体检测技术研究奠定基础。     

牛分枝杆菌MPB70蛋白单克隆抗体的制备及检测

为了制备牛分枝杆菌的单克隆抗体,本试验利用制备的原核表达的牛分枝杆菌重要抗原蛋白MPB70作为免疫原皮下多点注射免疫BALB/c小鼠。利用细胞融合技术,经过5次亚克隆与筛选,取已免疫好的小鼠脾细胞与SP2/0骨髓瘤细胞在PEG3500的作用下进行细胞融合。筛选得到了2株分泌抗牛分枝杆菌MPB70蛋白的杂交瘤细胞,分别命名为Anti-B-MPB70：8和Anti-B-MPB70：12。采用间接ELISA方法对获得的单克隆抗体进行亲和常数检测、效价分析及亚类鉴定,通过SDS-PAGE凝胶试验对单克隆抗体进行纯度分析,并检测其浓度,通过Western blotting方法对单克隆抗体的反应特性进行鉴定。结果显示,纯化后的MPB70蛋白分子质量大小为20 ku,浓度为0.5 mg/mL。两株单克隆抗体的亲和常数分别为9.95×10⁹和9.53×10⁸;抗体效价分别为1∶102 400和1∶12 800;抗体亚类分别为IgG_2b和IgG₁,轻链类型均为κ型;纯度>90%;浓度分别为3.0和2.2 mg/mL;且具有良好的反应特性。以上研究结果表明,本试验成功制备了抗MPB70蛋白单克隆抗体,可为牛结核病病原和抗体检测技术研究奠定基础。     

牛结核分枝杆菌早期标识性分泌性蛋白MPB70、MPB83基因的串联表达及其抗原性鉴定

为获得一种具有抗原性的牛结核分枝杆菌(MB)感染早期标识物MPB70、MPB83分泌性蛋白的串联抗原蛋白,本研究利用DNAStar生物信息软件对MB感染早期标识性分泌性蛋白MPB70、MPB83抗原结构区域进行预测后设计合成相应引物,并在两个片段之间引入16位柔性多肽,通过重叠延伸PCR技术获得MBP70与MBP83基因的抗原优势区核苷酸串联片段,将其连接至原核表达载体pGEX-6p-1中经诱导、表达,结果显示构建的重组表达载体获得高效表达,目的抗原蛋白的分子质量约58ku,纯化后重组蛋白的纯度>90%,经免疫BALB/c小鼠4次后,抗体效价达到1∶51200。本实验获得了具有明显抗原活性的MB感染早期分泌性蛋白串联抗原MPB70+MPB83,为后续进一步研发MB早期感染标识物快速检测试剂盒奠定了基础。     

牛干扰素单克隆抗体的制备与初步鉴定

通过IPTG诱导的大肠埃希菌表达重组牛干扰素-γ融合蛋白(BovIFN-γ),利用GlutathioneSepharose 4 Fast Flow亲和层析柱进行融合蛋白的纯化,纯化后的融合蛋白BovIFN-γ作为抗原免疫Balb/c小鼠,经5次免疫后,取小鼠脾细胞与SP2/0骨髓瘤细胞进行细胞融合,间接ELISA筛选,有限稀释法克隆亚克隆获得分泌BovIFN-γ单克隆抗体的杂交瘤细胞株,并通过ELISA方法对其抗体效价、特异性、亚类及稳定性进行鉴定。获得一株稳定分泌BovIFN-γ单克隆抗体的杂交瘤细胞株A12E9,细胞培养上清和腹水效价可达1∶3 200和1∶160 000。     

非洲猪瘟病毒p72蛋白原核表达及单克隆抗体制备

【目的】表达与纯化非洲猪瘟病毒(African swine fever virus, ASFV)p72蛋白,并制备其单克隆抗体。【方法】构建原核表达载体pET-28b-p72,转化大肠杆菌BL21(DE3)感受态细胞并进行诱导表达和蛋白纯化;用纯化后的p72蛋白免疫BALB/c小鼠,将免疫小鼠的脾细胞与骨髓瘤细胞进行细胞融合并制备单克隆抗体,通过间接ELISA法和亚克隆筛选出分泌抗体的阳性杂交瘤细胞;通过小鼠抗体类型检测试剂盒检测抗体类型;通过体内诱生法制备抗ASFV p72蛋白的单克隆抗体腹水,使用饱和硫酸铵沉淀法进行抗体纯化,通过间接ELISA法、间接免疫荧光试验(IFA)和Western blotting检测单克隆抗体效价和特异性。【结果】ASFV p72重组蛋白在大肠杆菌中以包涵体形式表达,将纯化的p72蛋白制备单克隆抗体,获得4株分泌IgG1抗体的单克隆细胞株,分别命名为6F8、7C3、8H7和9G2。间接ELISA结果显示,6F8与8H7细胞株分泌的抗体效价均为1∶64 00,7C3与9G2细胞株的抗体效价均为1∶12 800,且4株细胞株分泌的抗体与p72蛋白反应结果均呈...     

肠出血性大肠杆菌O157∶H7主要保护性抗原单克隆抗体的研制及特性分析

以基因重组技术构建工程菌株表达肠出血性大肠杆菌(EHEC)O157∶H7主要保护性抗原紧密素和志贺毒素的融合蛋白.融合蛋白采用凝胶分离电洗脱法回收纯化,用纯化的蛋白抗原免疫BALB/c小鼠,细胞融合后获得的3株杂交瘤细胞株1G2、3C6、1B10,能分别稳定分泌针对紧密素、志贺毒素Stx1和Stx2的单克隆抗体.3株单抗分别制备腹水并纯化,ELISA检测效价分别为1∶6.4×105、1∶1.2×106、1∶3 200.Western-blot检测表明,3株单抗与融合蛋白发生特异性反应.应用3株单抗均可特异性检出EHEC O157∶H7,而3株单抗与其他不产生紧密素和志贺毒素的大肠杆菌不反应.     

猪传染性胃肠炎病毒NSP8蛋白单克隆抗体的制备及抗原表位的初步鉴定

为鉴定猪传染性胃肠炎病毒(porcine transmissible gastroenteritis virus,TGEV)NSP8蛋白的抗原表位,本研究对GST-NSP8重组蛋白进行了原核表达,并用纯化后的重组蛋白免疫6周龄BALB/c小鼠,取免疫小鼠脾脏,采用常规杂交瘤细胞融合方法,经3次亚克隆后制备了1株稳定分泌抗NSP8蛋白的单克隆抗体杂交瘤细胞株。分泌的单克隆抗体亚类鉴定其重链为IgG1型,轻链为κ链;杂交瘤细胞培养上清的效价为1∶3 200。Western blotting试验结果表明该单克隆抗体能识别原核及真核表达的NSP8重组蛋白。利用截短表达的方法对NSP8蛋白进行抗原表位的鉴定,初步确定了单克隆抗体针对的抗原表位序列为31SPQILKQLTKAFNIAKSDFEREASV55。本研究制备的单克隆抗体及对抗原表位的鉴定,为TGEV NSP8蛋白相关功能的研究奠定了基础。     

猪传染性胃肠炎病毒M蛋白单克隆抗体的制备与鉴定

为了制备猪传染性胃肠炎病毒(TGEV)M蛋白的单克隆抗体(MAb),试验利用原核表达融合蛋白His-M免疫7周龄雌性Balb/c小鼠,以PK-15细胞培养病毒液作为检测筛选抗原,并采用淋巴细胞杂交瘤技术制备单克隆抗体。结果表明:获得2株稳定分泌抗体的阳性杂交瘤细胞株(2G1、2G2),经检测其细胞培养上清液和诱导的小鼠腹水抗体效价分别可达到1∶3 200和1∶1×10~5;连续培养15代及液氮冻存后复苏,抗体效价稳定;单克隆抗体亚型鉴定均为IgG1,轻链均为k链;MAb能够特异性识别TGEV。     

鸭疫里默氏杆菌pfs基因的克隆表达及单克隆抗体制备

将鸭疫里默氏杆菌的pfs基因进行原核表达,重组蛋白经纯化后作为抗原免疫BALB/c小鼠。经过3次免疫后,取免疫小鼠脾细胞与SP2/0骨髓瘤细胞进行细胞融合,利用间接ELISA方法筛选阳性杂交瘤细胞株。通过间接ELISA法测定腹水效价、Western blot法检测其免疫反应性,并鉴定抗体的亚型。重组蛋白SDS-PAGE检测结果验证得到26 k Da Pfs蛋白,免疫小鼠后最终获得1株阳性杂交瘤细胞株,命名为2E2E6,为Ig G1亚类,间接ELISA法检测腹水效价为1:64 000。Western blot结果表明制备的单克隆抗体具有良好的免疫反应性。本研究成功制备了Pfs的单克隆抗体,为进一步研究Pfs在鸭疫里默氏杆菌中的作用提供了参考。     

犬PD-1单克隆抗体的筛选与鉴定

为筛选犬程序性死亡受体1(cPD-1)单克隆抗体,以原核表达并纯化复性的cPD-1胞外区蛋白为靶抗原免疫BALB/c小鼠,应用单克隆抗体杂交瘤细胞技术和间接ELISA方法,经3轮轮筛选和克隆化,获得1株能稳定分泌抗cPD-1单克隆抗体的杂交瘤细胞株1F9。间接ELISA检测显示1F9杂交瘤细胞株连续传代培养能稳定分泌单克隆抗体,效价达到1∶2048,亚型鉴定重链为IgG1,轻链为κ;以HEK293细胞表达cPD-1胞外区蛋白为检测抗原,Western-blot和间接免疫荧光试验进行鉴定,结果显示1F9单克隆抗体能特异性结合cPD-1胞外区蛋白。本研究通过小鼠杂交瘤技术成功筛选到1株鼠源cPD-1单克隆抗体。     

Antigenic characterization of mycobacteria from South American wild seals.

Tuberculosis-producing mycobacteria have been previously described in marine mammals (Cousins et al., 1990, 1993; Romano et al., 1995; Bernardelli et al., 1996). The strains belonged to the M. tuberculosis complex (M. tuberculosis, M. bovis, M. microti and M. africanum), but showed genetic and biochemical differences. The antigenic composition of mycobacteria isolated from wild seals was analyzed by Western blots, using antibodies against some selected antigens. The antigenic content was compared with that of M. bovis, M. tuberculosis and M. microti isolates. The lack of Hsp65 protein in supernatants suggested a low degree of cell lysis in the three-week cultures used. SOD, P27 lipoprotein, MPB64 and antigen 85 were observed in all the strains studied. The wild seal strains, as well as M. tuberculosis, did not produce MPB70 and MPB83. Only very weak bands of P36 antigen were observed in culture supernatants from wild seal mycobacteria. Summarizing, the antigenic composition of mycobacterial strains from wild seals is different from M. bovis strains.     

Evaluation of three serological assays for the diagnosis of Mycobacterium bovis infection in brushtail possums

Three serological tests for the diagnosis of Mycobacterium bovis infection were evaluated on 29 possums (Trichosurus vulpecula) with tuberculosis and on 100 possums from a tuberculosis-free area. An indirect ELISA using M. bovis culture filtrate as the antigen had a sensitivity of 45% and a specificity of 96%, while an indirect ELISA using a M. bovis specific antigen (MPB70) had a sensitivity of 21% and a specificity of 98%. A blocking ELISA which utilised a monoclonal antibody against MPB70 had a sensitivity of 28% and a specificity of 99%. Combination of the test results of the three ELISAs resulted in an increase in sensitivity to 51% and a decrease in specificity to 93%. A previous study has shown that possums experimentally infected with M. bovis produced cellular responses to M. bovis antigens relatively early in the infection, but these responses decreased in the terminal stages of the disease. In contrast, analysis of serological responses in the current study from sequentially collected sera of possums experimentally and naturally infected with M. bovis showed that antibody was first detected late in the disease.     

牛型分枝杆菌MPB70蛋白胶乳凝集方法的建立及应用

为了研究牛结核病新型诊断试剂，提高诊断的特异性和敏感性，我们用大肠杆菌工程菌表达了牛型分枝杆菌特异性抗原MPB70并提纯蛋白建立了牛结核病乳胶凝集试验（LAT）诊断方法。MPB70是一种牛型分枝杆菌特异性分泌而卡介苗BCG缺失的蛋白质，热稳定性好，用此蛋白建立的乳胶凝集方法具有良好的敏感性、特异性以及较长的保存期，检测70份临床奶牛血清，与皮内变态反应和间接血凝方法相比较分别具有71．4％和88．6％的符合率。该方法还可鉴别诊断自然感染和疫苗免疫接种。我们建立的牛型分枝杆菌MPB70蛋白乳胶凝集试验诊断方法将分子生物学手段和经典试验方法有机结合，为临床快速检测牛结核病血清特异性抗体水平提供了行之有效的方法。     

牛结核病抗体胶体金快速检测技术的建立和应用

为了建立一种快速检测牛分支杆菌抗体的新方法用于诊断牛结核病,利用胶体金免疫层析技术原理,用原核诱导表达的牛分支杆菌抗原蛋白MPB83和MPB70分别作为胶体金标记抗原和检测线上的捕获抗原,制备牛结核抗体检测试纸条.结果表明,粒径为40 nm的胶体金制备的试纸条敏感性最高,胶体金最佳标记pH为6.0,MPB83抗原最适标记量为每毫升胶体金6.5 μg,MPB70抗原的最适包被浓度为3.0 mg/mL,抗MPB83蛋白IgG的最佳包被浓度为2.5 mg/mL,交叉试验证明试纸条不与牛的其他非相关疾病的阳性血清反应,具有较高的特异性.比较试验证明其敏感性显著高于韩国进口试纸条.在上述试验条件下生产了一批胶体金试纸条进行临床样品检测,并与细菌分离培养、结核菌素皮内变态反应(TST)和韩国试纸条比较.本试纸条与牛分支杆菌分离培养的符合率为85%,与TST的符合率为79.73%,与韩国试纸条的符合率为98.75%.快速检测牛结核抗体的免疫层析试纸条具有敏感、特异、简便、快速的特点,适用于对牛结核病进行普查和检疫,也可作为TST的辅助诊断方法,在牛结核病根除计划中具有良好的应用前景.     

11种牛分枝杆菌抗原在牛结核病诊断中的初步评价

为筛选及评价用于牛结核病诊断的抗原,本试验将CFP-10、ESAT-6、TB10.4、TB27.4、MPT51、MPT63、MPT64、MPB70、MPB83、Rv3872和Ag85B共11种牛分枝杆菌抗原分别作为包被抗原建立间接ELISA方法,比较其对牛结核病的检出率;同时利用豚鼠和牛的皮试试验评价重组蛋白作为皮试试验刺激原的潜力。此外,将重组蛋白分别刺激结核病阳性牛和阴性牛的抗凝血24 h,检测血浆中的IFN-γ水平,评价各重组蛋白作为IFN-γ释放试验刺激原的潜力。结果显示,不同重组蛋白对结核病阳性血清的反应活性不一,MPB70总检出率最高,为59.7%;其次是Ag85B、ESAT-6和MPB83,检出率均在45%以上;MPT51的检出率最低,仅为2.2%。豚鼠和牛皮试试验均显示,单个重组蛋白作为刺激原难以产生令人满意的迟发型过敏反应（delayed type hypersensitivity,DTH）,而TB10.4、TB27.4、MPT64、MPT63或Rv3872作为补充抗原,分别与CFP-10或ESAT-6混合,均可特异性地刺激结核病阳性牛产生较强的DTH反应,且与PPD-B无显著差异（P>0.05）。重组蛋白CFP-10、ESAT-6、TB10.4和MPT51均能刺激结核病牛全血释放一定的IFN-γ,其中CFP-10、CFP-10-ESAT-6串联蛋白和MPT51刺激结核病阳性牛全血释放的IFN-γ显著高于阴性牛（P<0.05）。因此,这11种牛分枝杆菌抗原并不适合单独用于牛结核病的血清学诊断、皮试试验或IFN-γ释放试验,但以CFP-10和ESAT-6为核心,TB10.4、TB27.4、MPT64、MPT63、Rv3872或MPT51作为其补充抗原,均能提高检测敏感性,有作为皮试试验和IFN-γ释放试验特异性刺激原用于牛结核病诊断的潜力。     

A DNA vaccine encoding MPB83 from Mycobacterium bovis reduces M. bovis dissemination to the kidneys of mice and is expressed in primary cell cultures of the European badger (Meles meles)

Nucleic acid (DNA) vaccination against tuberculosis in the European badger (Meles meles) is one approach to addressing the escalating problem of bovine tuberculosis in Great Britain. The aim of vaccination is to reduce the burden of tuberculosis within the badger population and the shedding of Mycobacterium bovis to levels that would break the transmission of infection to cattle. To this end, the vaccine would be required to limit the amount of disseminated tuberculosis in the badger, especially dissemination to the kidney from where M. bovis can be shed in the urine. A promising candidate DNA vaccine encoding a 26 kDa major antigen (MPB83) of M. bovis was evaluated in a mouse model of disseminated M. bovis infection. Using the DNA vaccine, protection against infection of the kidney was found to be greater than that achieved with the current live vaccine, Bacille Calmette-Guerin (BCG). Kidney tissue and skeletal muscle from the badger was used to derive primary cell cultures in which to examine the expression of MPB83 following transfection with the DNA vaccine. Kidney cortex gave rise to a monotypic culture of epithelial cells whilst the muscle gave rise to a mixed culture of fibroblasts and myoblasts. During culture the myoblasts differentiated into multinucleated myotubes, verified by immunofluorescent detection of mammalian desmin. Successful expression of MPB83 by transfected epithelial and myotube cells was confirmed by immunofluorescence using a monoclonal antibody specific to the protein. These observations fulfil the early requirements for the development of a DNA vaccine for badger tuberculosis.     

Tuberculosis in domesticated red deer: Comparison of purified protein derivative and the specific protein MPB70 for in vitro diagnosis

The use of a Mycobacterium bovis-specific protein, mycobacterial protein bovis 70 (MPB70), was compared with complex, M bovis-derived purified protein derivative (bovine PPD), for its ability to improve the diagnostic precision of in vitro assays for tuberculosis in farmed deer. A combination of lymphocyte transformation and enzyme-linked immunosorbent assay (ELISA) was used to differentiate between specific M bovis reactivity and crossreactivity due to sensitisation with saprophytic mycobacteria such as Mycobacterium avium. In the lymphocyte transformation assay the response of mononuclear cells, from red deer, to MPB70 was found to be more specific, but less sensitive, as an indicator of infection by M bovis when compared with the complex antigen bovine PPD. When used in conjunction with bovine PPD alone, MPB70 was found to increase the specificity of the ELISA in diagnosing animals with disease.     

Competitive and indirect enzyme-linked immunosorbent assays for Mycobacterium bovis infections based on MPB70 and lipoarabinomannan antigens.

A competitive enzyme-linked immunosorbent assay (C-ELISA) using M. bovis BCG Tokyo culture filtrate as antigen and anti-MPB70 4C3/17 monoclonal antibody was developed for use in multiple animal species. An analysis of the C-ELISA data for cattle and bison serum panels revealed specificities of 68% to 85% and sensitivities of 85% to 89%. Receiver operator characteristics (ROC) of this data revealed areas of 81% to 92% for C-ELISA and demonstrated that C-ELISA as well as the indirect ELISA protocols, MPB70-ELISA and LAM-ELISA, discriminate M. bovis infected animals from non-infected animals for these particular panels. The kappa statistic values for agreement beyond chance between C-ELISA and MPB70-ELISA were determined after ELISA cutoffs were adjusted to minimize false positives. There were poor to excellent agreements between C-ELISA and MPB70-ELISA in all species tested (Bovidae, Cervidae, and Camelidae) that were consistently higher than the kappa statistic between C-ELISA and LAM-ELISA. The humoral response to one antigen and little or no response to the other in many animals argued for a parallel interpretation of C-ELISA and LAM-ELISA to increase sensitivity.     

Differential antigen recognition by serum antibodies from three bovid hosts of Mycobacterium bovis infection

Cattle, bison and buffaloes are susceptible to Mycobacterium bovis, the causative agent for bovine tuberculosis. Accurate and timely identification of infected animals is critical for improved management and control of disease in these species. Bovids develop humoral immune responses to M. bovis infection making serological tests attractive for tuberculosis screening. However, optimization and validation of antibody assays designed for various animal species require understanding of antigen recognition patterns in each target host. The objective of this study was to characterize serological reactivity profiles generated by cattle, American bison, and African buffaloes in tuberculosis. Serum samples from M. bovis-infected animals were tested for the presence of IgM and IgG antibodies to MPB70/MPB83 and CFP10/ESAT6 chimeric proteins using Dual-Path Platform technology. All three host species showed IgG responses of higher magnitude and frequency than IgM responses; further, IgM seroreactivity was limited to MPB70/MPB83, whereas IgG antibodies recognized both test antigens. In cattle, the IgM and IgG responses were elicited mainly by MPB70/MPB83, whereas bison and buffaloes showed similar IgG seroreactivity rates for MPB70/MPB83 and CFP10/ESAT6 antigens. The findings demonstrate distinct patterns of predominant antigen recognition by different bovid species in M. bovis infection.